Delivery Order SPE2DB22D2006-SPE2DB23FV9CN

Award Date 4/17/23
Potential Completion Date 4/18/23
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Rizatriptan 5 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical. The $1,099.84 firm-fixed-price delivery order has an ultimate completion date of August 16, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The contract covers the delivery of 4,560,747,942 units of Rizatriptan 10 mg Orally Disintegrating Tablets in 18-count packages, at a ceiling value of $2,092.84. This contract does not have a...
The federal contract award is for pharmaceutical products, specifically Rizatriptan 10 mg tablets, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $5,078.75, with a completion date of September 19, 2023. The contracting agency is the Defense Logistics Agency (DLA), a defense agency, and the contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,580.12 firm fixed-price delivery order covers the supply of 4557635156 units of Rizatriptan 10 mg Orally Disintegrating Tablets with a completion date of June 27, 2022. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D1106|SPE2DB23FEHM1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,702.84 delivery order contract is for the supply of Rizatriptan 10 mg tablets to support defense healthcare programs. The contract is a firm fixed-price, non-set-aside award with a completion date of May 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Rizatriptan 10 mg tablets to the Defense Logistics Agency (DLA). The $1,046.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 9, 2021, with a completion date of November 10, 2021. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,804.46, is a delivery order for the supply of Rizatriptan 5 mg tablets. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This federal contract award is for the delivery of Rizatriptan 10 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,344.16 and runs through May 15, 2023. It is a delivery order contract with a firm fixed-price pricing type. The contract was awarded on May 12, 2023 and was not set aside for any specific business category....
This federal contract award is for the delivery of rizatriptan 10 mg tablets to the Defense Logistics Agency (DLA). The $2,526.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on October 24, 2024, with an ultimate completion date of October 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,896.14 firm fixed-price delivery order is for the supply of 4560678275 units of Rizatriptan 10 mg tablets, an acute migraine medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC, which runs through...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB23FV9CN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,000.54 Firm Fixed Price Delivery Order is for the supply of 4560615859 - Rizatriptan 10 mg Tablet UD 18s. The contract has an ultimate completion date of April 18, 2023.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation associated with this award.

Generated 5/9/25, 9:57 AM